Clinical trial
Ramipril for the Treatment of Oligospermia: A Double-Blind Randomized Control Trial
NCT01856361 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ramipril for the Treatment of Oligospermia: A Double-Blind Randomized Control Trial
- Lead sponsor
- Weill Medical College of Cornell University
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- July 31, 2013
- Completion date
- June 30, 2016
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
asthenozoospermia, male infertility, oligospermia, teratospermia